Refer a Friend
Do you know someone with agitation associated with Alzheimer's dementia, or a carer who's loved one is showing signs of agitated behavior? They may be eligible to participate in the TRIAD Research Study.
About Agitation:
Common behaviors of agitation associated with Alzheimer's dementia may include cursing, screaming, hitting, throwing things, kicking, pacing or wandering, and restlessness.
Learn More
Patient Eligibility:
To qualify for this study, individuals must be 50 to 90 years old, and have symptoms of agitation associated with Alzheimer's dementia. Additional criteria apply.
Learn More
About the Study:
The TRIAD Research Study is evaluating an investigational drug to determine if it reduces the symptoms of agitation associated with Alzheimer's dementia in participants.
Learn More
About AGITATION
Patients diagnosed with Alzheimer's dementia are known to have memory problems. Less well known is that some patients with Alzheimer's dementia may also have certain behavioral changes called agitation. These behaviors can be very disturbing for patients and their loved ones. Examples of some easily identified agitated behaviors are: restlessness, repeating questions, wandering, pointing fingers, rocking, yelling, screaming, cursing, hitting self or others, kicking, pushing, resisting, throwing objects, and slamming doors. Do any of these behavioral changes describe you or your loved one?
People with Alzheimer's dementia showing signs of agitated behavior may be eligible to enroll in the TRIAD Research Study.
READ MORE ABOUT AGITATION
16
Weeks
9
Clinic Visits
2
Daily Dose
1
Study Diary
The TRIAD Research Study
Study Overview
The purpose of this research study is to test an investigational drug (also called the study drug) to determine if it might reduce the symptoms of agitation associated with Alzheimer's dementia, as well as testing its safety and tolerability in participants. At this time, there are no medications approved to treat patients diagnosed with agitation associated with Alzeimer's dementia. By participating in the TRIAD Research Study, you could help to advance future treatment options for this condition.
To participate in this study, volunteers must:
- • Be 50 to 90 years old
- • Have moderate to severe agitation associated with Alzheimer’s dementia
- • Have a carer who can attend all study visits
Additional criteria for eligibility will apply.
COMPLETE THE ELIGIBILITY QUESTIONNAIRE